MGNX
MacroGenics, Inc. Healthcare - Biotechnology Investor Relations →
MacroGenics, Inc. (MGNX) closed at $1.81 as of 2026-02-02, trading 64.1% below its 200-week moving average of $5.04. This places MGNX in the extreme value zone. The stock is currently moving closer to the line, down from -63.9% last week. The 14-week RSI sits at 55, indicating neutral momentum.
Over the past 595 weeks of data, MGNX has crossed below its 200-week moving average 10 times. On average, these episodes lasted 43 weeks. The average one-year return after crossing below was -30.9%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $114 million, MGNX is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -81.1%. The stock trades at 1.7x book value.
Share count has increased 2.5% over three years, indicating dilution.
Over the past 11.5 years, a hypothetical investment of $100 in MGNX would have grown to $9, compared to $426 for the S&P 500. MGNX has returned -19.2% annualized vs 13.4% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: MGNX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MGNX Crosses Below the Line?
Across 10 historical episodes, buying MGNX when it crossed below its 200-week moving average produced an average return of -32.1% after 12 months (median -19.0%), compared to +6.3% for the S&P 500 over the same periods. 20% of those episodes were profitable after one year. After 24 months, the average return was -33.3% vs +19.2% for the index.
Each line shows $100 invested at the moment MGNX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MGNX has crossed below its 200-week MA 10 times with an average 1-year return of +-30.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2014 | Nov 2014 | 9 | 28.9% | +32.5% | -91.6% |
| Aug 2015 | Oct 2015 | 9 | 20.8% | +9.0% | -93.6% |
| Jan 2016 | Jul 2016 | 27 | 43.5% | -18.5% | -92.7% |
| Oct 2016 | Nov 2016 | 4 | 23.6% | -30.5% | -92.8% |
| Nov 2016 | Feb 2018 | 65 | 39.9% | -26.2% | -93.1% |
| Apr 2018 | May 2020 | 109 | 74.5% | -12.7% | -92.0% |
| Sep 2021 | Sep 2021 | 1 | 0.4% | -84.6% | -90.8% |
| Oct 2021 | Nov 2021 | 3 | 3.7% | -82.2% | -90.8% |
| Nov 2021 | Jan 2024 | 115 | 87.1% | -65.1% | -90.2% |
| May 2024 | Ongoing | 92+ | 87.8% | Ongoing | -45.3% |
| Average | 43 | — | +-30.9% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02